Developing Precision Medicine Approaches: To create personalized treatment plans for patients with Alzheimer's disease (AD), Parkinson's disease (PD), and Dementia with Lewy Bodies (DLB) by integrating genetic, biomarker, and clinical data.
Innovative Therapeutic Strategies: To identify new drug targets and therapeutic interventions aimed at enhancing cellular clearance mechanisms in neurodegenerative diseases.
Early Diagnosis and Prevention: To develop reliable biomarkers and advanced imaging techniques for early diagnosis and potential prevention strategies for neurodegenerative diseases.
Understanding Disease Mechanisms: To elucidate the molecular and cellular pathways involved in the onset and progression of neurodegenerative diseases, with an emphasis on translational research.
Enhancing Patient Outcomes: To improve the quality of life and clinical outcomes for patients through the development of novel diagnostic tools and therapeutic strategies.
Collaborative Research Networks: To establish and expand collaborative research networks between different institutions and disciplines, fostering a multidisciplinary approach to tackling neurodegeneration.
Knudtzon S, Nordengen K, Pålhaugen L, Gísladóttir B, Jarholm J, Bråthen G, Skogseth RE, Waterloo K, Selnes P, Fladby T, Kirsebom BE(2025) Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's disease Brain Commun, 7(3), fcaf161 DOI 10.1093/braincomms/fcaf161, PubMed 40322776
Sannes I, Harr ME, Antal EA, Beyer MK, Nordengen K(2025) Acute hemorrhagic leukoencephalitis with gradual symptom onset: Case Report and literature review Front Neurosci, 19, 1557046 DOI 10.3389/fnins.2025.1557046, PubMed 40236944
Vold V, Tingvoll SH, Beyer MK, Nordengen K(2025) Case report: Re-evaluating reversibility of cytotoxic lesions of the corpus callosum Front Neuroimaging, 4, 1436931 DOI 10.3389/fnimg.2025.1436931, PubMed 40034189